Thermo Fisher Scientific Avian Influenza H5N1 Neuraminidase Polyclonal Antibody

Applications

Western Blot (WB)

• Tested Dilution: 1:500–1:3,000

ELISA

• Tested Dilution: Not specified

Publications

• View 1 publication

Product Specifications

Product Specific Information

Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.

Target Information

Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic.

Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins elicit immune responses that prevent infection or reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain combining a triple assortment identified in 1998, including human, swine, and avian influenza, with two new pig H3N2 virus genes from Eurasia of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) suggest limited human immunity, though some protection may exist in older age groups.

⚠ WARNING: This product can expose you to chemicals including mercury, known to the State of California to cause birth defects or other reproductive harm.
For more information, visit www.P65Warnings.ca.gov.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.